Artemisinin resistance – modelling the potential human and economic costs

BACKGROUND: Artemisinin combination therapy is recommended as first-line treatment for falciparum malaria across the endemic world and is increasingly relied upon for treating vivax malaria where chloroquine is failing. Artemisinin resistance was first detected in western Cambodia in 2007, and is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Lubell, Yoel, Dondorp, Arjen, Guérin, Philippe J, Drake, Tom, Meek, Sylvia, Ashley, Elizabeth, Day, Nicholas PJ, White, Nicholas J, White, Lisa J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254187/
https://www.ncbi.nlm.nih.gov/pubmed/25418416
http://dx.doi.org/10.1186/1475-2875-13-452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254187/
https://www.ncbi.nlm.nih.gov/pubmed/25418416
http://dx.doi.org/10.1186/1475-2875-13-452

Ejemplares similares